By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Spectrum Pharmaceuticals, Inc. 

157 Technology Drive

Irvine  California  92618  U.S.A.
Phone: 949-788-6700 Fax: 949-788-6706


SEARCH JOBS


Industry
Pharmaceutical

Segment
Oncology





Company News
Spectrum Pharma (SPPI) Highlights An Oral Presentation On Apaziquone At The 2016 Annual Meeting Of The American Urological Association Education And Research Inc. (AUA) In San Diego, California, May 6-10, 2016 5/6/2016 9:13:25 AM
Spectrum Pharma (SPPI) Reports First Quarter 2016 Financial Results And Pipeline Update 5/6/2016 8:55:33 AM
Spectrum Pharma (SPPI) To Present Corporate Update At The Bank of America (BAC) Merrill Lynch 2016 Healthcare Conference On May 10th 5/3/2016 11:17:34 AM
Spectrum Pharma (SPPI) Announces First Quarter 2016 Financial Results Teleconference And Webcast 4/28/2016 11:14:34 AM
Spectrum Pharma (SPPI) Release: FDA Grants Orphan Drug Exclusivity To EVOMELA (melphalan) For Injection, Indicated For Multiple Myeloma 4/20/2016 11:36:52 AM
Ligand (LGND) Partner Spectrum Pharma (SPPI) Receives FDA Approval Of EVOMELA (Melphalan) For Injection 3/15/2016 10:49:35 AM
FDA Grants Spectrum Pharma (SPPI) Approval Of EVOMELA (Melphalan) For Injection 3/15/2016 10:31:41 AM
Spectrum Pharma (SPPI) Reports Fourth Quarter 2015 And Full Year 2015 Financial Results And Pipeline Update 3/10/2016 10:26:16 AM
Spectrum Pharma (SPPI) Initiates Phase 2 Breast Cancer Trial For Poziotinib, A Novel Pan-HER Inhibitor 3/7/2016 12:14:10 PM
Spectrum Pharma (SPPI) Announces Fourth Quarter And Full Year 2015 Financial Results Teleconference And Webcast 3/2/2016 11:39:43 AM
12345678910...
//-->